Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Momordica charantia:

Search results

Items: 1 to 20 of 934

1.

Comparison of antidiabetic effects of saponins and polysaccharides from Momordica charantia L. in STZ-induced type 2 diabetic mice.

Wang Q, Wu X, Shi F, Liu Y.

Biomed Pharmacother. 2019 Jan;109:744-750. doi: 10.1016/j.biopha.2018.09.098. Epub 2018 Nov 5.

2.

Study of pancreatic lipase inhibition kinetics and LC-QTOF-MS based identification of bioactive constituents of Momordica charantia fruits.

Chanda J, Mukherjee PK, Biswas R, Malakar D, Pillai M.

Biomed Chromatogr. 2018 Dec 9:e4463. doi: 10.1002/bmc.4463. [Epub ahead of print]

PMID:
30536964
3.

Effect of Bitter Melon Extracts on Lipid Levels in Japanese Subjects: A Randomized Controlled Study.

Kinoshita H, Ogata Y.

Evid Based Complement Alternat Med. 2018 Nov 8;2018:4915784. doi: 10.1155/2018/4915784. eCollection 2018.

4.

Chemosynthesis and characterization of site-specific N-terminally PEGylated Alpha-momorcharin as apotential agent.

Sun W, Sun J, Zhang H, Meng Y, Li L, Li G, Zhang X, Meng Y.

Sci Rep. 2018 Dec 7;8(1):17729. doi: 10.1038/s41598-018-35969-1.

5.

Administration of Momordica charantia Enhances the Neuroprotection and Reduces the Side Effects of LiCl in the Treatment of Alzheimer's Disease.

Huang HJ, Chen SL, Chang YT, Chyuan JH, Hsieh-Li HM.

Nutrients. 2018 Dec 3;10(12). pii: E1888. doi: 10.3390/nu10121888.

6.

Oxalate content of raw, wok-fried, and juice made from bitter gourd fruits.

Bong WC, Savage G.

Food Sci Nutr. 2018 Oct 23;6(8):2015-2019. doi: 10.1002/fsn3.706. eCollection 2018 Nov.

7.

Safety and efficacy of Momordica charantia Linnaeus in pre-diabetes and type 2 diabetes mellitus patients: a systematic review and meta-analysis protocol.

Peter EL, Deyno S, Mtewa A, Kasali FM, Nagendrappa PB, Sesaazi D, Tolo CU, Ogwang PE.

Syst Rev. 2018 Nov 15;7(1):192. doi: 10.1186/s13643-018-0847-x.

8.

Mapping and QTL Analysis of Gynoecy and Earliness in Bitter Gourd (Momordica charantia L.) Using Genotyping-by-Sequencing (GBS) Technology.

Gangadhara Rao P, Behera TK, Gaikwad AB, Munshi AD, Jat GS, Boopalakrishnan G.

Front Plant Sci. 2018 Oct 31;9:1555. doi: 10.3389/fpls.2018.01555. eCollection 2018.

9.

Enzymes inhibitors from natural sources with antidiabetic activity: A review.

Alam F, Shafique Z, Amjad ST, Bin Asad MHH.

Phytother Res. 2018 Nov 11. doi: 10.1002/ptr.6211. [Epub ahead of print] Review.

PMID:
30417583
10.

Bitter melon (Momordica charantia) attenuates atherosclerosis in apo-E knock-out mice possibly through reducing triglyceride and anti-inflammation.

Zeng Y, Guan M, Li C, Xu L, Zheng Z, Li J, Xue Y.

Lipids Health Dis. 2018 Nov 6;17(1):251. doi: 10.1186/s12944-018-0896-0.

11.

Preparation of a Momordica charantia L. polysaccharide‑chromium (III) complex and its anti-hyperglycemic activity in mice with streptozotocin-induced diabetes.

Zhang C, Huang M, Hong R, Chen H.

Int J Biol Macromol. 2018 Nov 2;122:619-627. doi: 10.1016/j.ijbiomac.2018.10.200. [Epub ahead of print]

PMID:
30391593
12.

Antihyperglycemic and Antilipidemic Effects of the Ethanol Extract Mixture of Ligularia fischeri and Momordica charantia in Type II Diabetes-Mimicking Mice.

Baek HJ, Jeong YJ, Kwon JE, Ra JS, Lee SR, Kang SC.

Evid Based Complement Alternat Med. 2018 Oct 2;2018:3468040. doi: 10.1155/2018/3468040. eCollection 2018.

13.

Momordica charantia L. lowers elevated glycaemia in type 2 diabetes mellitus patients: Systematic review and meta-analysis.

Peter EL, Kasali FM, Deyno S, Mtewa A, Nagendrappa PB, Tolo CU, Ogwang PE, Sesaazi D.

J Ethnopharmacol. 2018 Oct 30;231:311-324. doi: 10.1016/j.jep.2018.10.033. [Epub ahead of print] Review.

PMID:
30385422
14.

Molecular concept of diabetic wound healing: effective role of herbal remedies.

Soliman A, Teoh SL, Ghafar N, Das S.

Mini Rev Med Chem. 2018 Oct 25. doi: 10.2174/1389557518666181025155204. [Epub ahead of print]

PMID:
30360709
15.

Cucurbitane triterpenoids from the fruit of Momordica charantia L. and their anti-hepatic fibrosis and anti-hepatoma activities.

Yue J, Sun Y, Xu J, Cao J, Chen G, Zhang H, Zhang X, Zhao Y.

Phytochemistry. 2019 Jan;157:21-27. doi: 10.1016/j.phytochem.2018.10.009. Epub 2018 Oct 22.

PMID:
30352327
16.

Momordica charantia extracts protect against inhibition of endothelial angiogenesis by advanced glycation endproducts in vitro.

Aljohi A, Matou-Nasri S, Liu D, Al-Khafaji N, Slevin M, Ahmed N.

Food Funct. 2018 Nov 14;9(11):5728-5739. doi: 10.1039/c8fo00297e.

PMID:
30318521
17.

Identification of triterpene biosynthetic genes from Momordica charantia using RNA-seq analysis.

Takase S, Kera K, Hirao Y, Hosouchi T, Kotake Y, Nagashima Y, Mannen K, Suzuki H, Kushiro T.

Biosci Biotechnol Biochem. 2018 Oct 13:1-11. doi: 10.1080/09168451.2018.1530096. [Epub ahead of print]

PMID:
30317922
18.

Molecular docking analysis of phytoconstituent from Momordica charantia with Guanylate Cyclase catalytic domain.

Ghanta M, Panchanathan E, Lakkakula BVKS, Narayanaswamy A, Abhinand PA, Antony S.

Bioinformation. 2018 Jul 31;14(7):378-383. doi: 10.6026/97320630014378. eCollection 2018.

19.
20.

Polysaccharide from fermented Momordica charantia L. with Lactobacillus plantarum NCU116 ameliorates type 2 diabetes in rats.

Gao H, Wen JJ, Hu JL, Nie QX, Chen HH, Xiong T, Nie SP, Xie MY.

Carbohydr Polym. 2018 Dec 1;201:624-633. doi: 10.1016/j.carbpol.2018.08.075. Epub 2018 Aug 27.

PMID:
30241862

Supplemental Content

Loading ...
Support Center